182 related articles for article (PubMed ID: 21140034)
1. False positive and false negative thyroid 99mTc-sestamibi scintigraphy in the same patient.
Gholamrezanezhad A; Muckle M; Ahmadzadehfar H; Biersack HJ; Ezziddin S
Nuklearmedizin; 2010; 49(6):N69-70. PubMed ID: 21140034
[No Abstract] [Full Text] [Related]
2. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
3. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
Del Castillo-Matos R; Quirce R; MartÃnez-RodrÃguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
[No Abstract] [Full Text] [Related]
4. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P
Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
[TBL] [Abstract][Full Text] [Related]
5. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
6. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
[No Abstract] [Full Text] [Related]
7. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
Paloyan E; Walker RP; Lawrence AM
Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
[TBL] [Abstract][Full Text] [Related]
8. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
Rashid K; Johns W; Chasse K; Walker M; Gupta SM
Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
[No Abstract] [Full Text] [Related]
9. 99mTc-MIBI in differentiated thyroid carcinoma.
Roelants V; Beckers C
J Nucl Med; 1999 Oct; 40(10):1769. PubMed ID: 10520721
[No Abstract] [Full Text] [Related]
10. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan.
Kaya M; Cermik TF
Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510
[TBL] [Abstract][Full Text] [Related]
11. [Iodine scintigraphy of differentiated thyroid carcinoma].
Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
[No Abstract] [Full Text] [Related]
12. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
Ng DC; Sundram FX; Sin AE
J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
[TBL] [Abstract][Full Text] [Related]
13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-SestaMIBI scintigraphy of thyroid gland in a patient with primary hyperparathyroidism: unusual features due to coesistence of a thyroid papillary carcinoma.
Boi F; Cau R; Piga M; Serra A; Loy M; Lai ML; Mariotti S
Clin Endocrinol (Oxf); 2003 Dec; 59(6):823-4. PubMed ID: 14974929
[No Abstract] [Full Text] [Related]
15. Incidental findings with Tc-99m MIBI imaging for parathyroid adenoma.
Hustad KV; Staub UH; Bud Mi; Hardersen R; Jaeger S; Brekke OL
Clin Nucl Med; 2007 Jul; 32(7):548-50. PubMed ID: 17581343
[No Abstract] [Full Text] [Related]
16. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
Bhargava P; Choi WS
Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
[No Abstract] [Full Text] [Related]
17. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky AZ; Freeman LM
J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
[No Abstract] [Full Text] [Related]
18. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
19. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]